PRIMEBODY
Live / Applied — New application — assigned to an examiner (as of 25 Mar 2026)
What this means for you
Not registered yet, but its 19 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99503974
- Mark type
- Stylized text
- Filed
- 19 Nov 2025
- Attorney of record
- Gayani R Weerasinghe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, pro drug or drug delivery systems comprising biologics for conditional activation, tissue or tumor targeting; therapeutic and diagnostic agents, preparations, and substances for medical purposes; pharmaceutical preparations and substances for use in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; therapeutic and diagnostic agents and preparations consisting primarily of biochemicals for medical use
- Class 042 — Scientific and technological services: Scientific and technological research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated or tumor-activated therapeutics or biologics; providing a scientific and technological platform for research and development of drug candidates; conducting clinical and pre-clinical research in the field of pharmaceuticals and biotechnology; pharmaceutical research, development, and analysis, namely relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; providing scientific information and data relating to pharmaceutical, biotechnological, and clinical research
Owner
- Voro Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 25 Mar 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Nov 2025 — NEW APPLICATION ENTERED